Cargando…

Antiarrhythmic Drugs for Atrial Fibrillation: Selected Features of Ventricular Repolarization That Facilitate Proarrhythmic Torsades de Pointes and Favor Inpatient Initiation

The management approaches to patients with atrial fibrillation (AF) include rhythm-control strategies for those patients who are symptomatic despite rate control and for selected others in whom sinus rhythm is necessary for reasons beyond current symptoms (including commercial pilots, those who are...

Descripción completa

Detalles Bibliográficos
Autor principal:	Reiffel, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2021
Materias:	Research Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313184/ https://www.ncbi.nlm.nih.gov/pubmed/34327046 http://dx.doi.org/10.19102/icrm.2021.120704

Ejemplares similares

Atrial Tachycardias Arising from Ablation of Atrial Fibrillation: A Proarrhythmic Bump or an Antiarrhythmic Turn?
por: Shah, Ashok J., et al.
Publicado: (2010)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Effects of diclofenac on ventricular muscle repolarization: proarrhythmic implications
por: Jost, Norbert, et al.
Publicado: (2011)

Class III Antiarrhythmics and Periprocedural Torsades de Pointes
por: Font, Cristina M., et al.
Publicado: (2023)

Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic Effects
por: Akman, Tulay, et al.
Publicado: (2014)

Proarrhythmic Remodeling of Atrial Myocyte Ca(2+) Handling in Atrial Fibrillation
por: Houser, Steven R.
Publicado: (2023)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Methadone induced torsades de pointes and ventricular fibrillation: A case review
por: Khalesi, Somayeh, et al.
Publicado: (2014)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
por: Nordkin, Irina, et al.
Publicado: (2020)

Atrial Fibrillation-triggered Ventricular Fibrillation in a Patient with Early Repolarization Syndrome
por: Takahashi, Masaki, et al.
Publicado: (2021)

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
por: Reiffel, James A.
Publicado: (2020)

Probable Hypocalcemia Induced Ventricular Fibrillation and Torsades de Pointes following Blood Product Administration
por: Mosebach, Christian M, et al.
Publicado: (2018)

Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
por: Reiffel, James A, et al.
Publicado: (2023)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

Torsade de Pointes Due to QT Prolongation after Pulmonary Vein Isolation for Persistent Atrial Fibrillation
por: Chikata, Akio, et al.
Publicado: (2021)

Meta‐analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation
por: Mao, Yin‐jun, et al.
Publicado: (2021)

Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia
por: Bögeholz, Nils, et al.
Publicado: (2018)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Electrical organization of torsades de pointes into monomorphic ventricular tachycardia
por: Gouda, Pishoy, et al.
Publicado: (2020)

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation
por: Shimizu, Masato, et al.
Publicado: (2016)

A fatal case of repeated ventricular fibrillation due to torsade de pointes following repeated administration of metoclopramide
por: Watanabe, Yusuke, et al.
Publicado: (2022)

TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY
por: Lakušić, Nenad, et al.
Publicado: (2019)

Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient
por: Reiffel, James A.
Publicado: (2019)

Contrast‐induced early repolarization pattern and ventricular fibrillation
por: Kariki, Ourania, et al.
Publicado: (2021)

Short-term Variability of Repolarization Is Superior to Other Repolarization Parameters in the Evaluation of Diverse Antiarrhythmic Interventions in the Chronic Atrioventricular Block Dog
por: Bossu, Alexandre, et al.
Publicado: (2017)

Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation
por: Tagami, Takashi, et al.
Publicado: (2017)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study
por: Tsumoto, Kunichika, et al.
Publicado: (2014)

Short-Coupled Variant of "Torsades de Pointes" and Polymorphic Ventricular Tachycardia
por: Chokr, Muhieddine Omar, et al.
Publicado: (2014)

Atrial pacing successfully suppressed drug-resistant ventricular fibrillation in a patient with early repolarization syndrome
por: Nishiwaki, Shushi, et al.
Publicado: (2022)

Severe Bradycardia Increases the Incidence and Severity of Torsade de Pointes Arrhythmias by Augmenting Preexistent Spatial Dispersion of Repolarization in the CAVB Dog Model
por: van Weperen, Valerie Y. H., et al.
Publicado: (2021)

A tale of 2 torsades: How to approach a patient with torsades de pointes and distinguish between classical and pseudo–torsades de pointes
por: Scheinman, Melvin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6q93admliggqjnlf79mrqlfoe6